Matthew C Findlay, Richard Drexler, Mohammed Azab, Arian Karbe, Roman Rotermund, Franz L Ricklefs, Jörg Flitsch, Timothy R Smith, John L Kilgallon, Jürgen Honegger, Isabella Nasi-Kordhishti, Paul A Gardner, Zachary C Gersey, Hussein M Abdallah, John A Jane, Alexandria C Marino, Ulrich J Knappe, Nesrin Uksul, Jamil A Rzaev, Anatoliy V Bervitskiy, Henry W S Schroeder, Márton Eördögh, Marco Losa, Pietro Mortini, Rüdiger Gerlach, Apio C M Antunes, William T Couldwell, Karol P Budohoski, Robert C Rennert, Michael Karsy
BACKGROUND AND OBJECTIVES: Crooke cell adenomas (CCA) are a rare, aggressive subset of adrenocorticotrophin secreting pituitary corticotroph adenomas (sCTA) found in 5-10% of patients with Cushing's disease. Multiple studies support worse outcomes in CCA but are limited by small sample size and single-institution databases. We compared outcomes in CCA and sCTA using a multicenter, international retrospective database of high-volume skull base centers. METHODS: Patients surgically treated for pituitary adenoma from January 2017 through December 2020 were included...
September 25, 2023: World Neurosurgery